The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase I trial of 5-aza-4’-thio-2’-deoxycytidine (Aza-TdC) in patients with advanced solid tumors.
 
James Nguyen
No Relationships to Disclose
 
Geraldine Helen O'Sullivan Coyne
No Relationships to Disclose
 
Naoko Takebe
No Relationships to Disclose
 
Abdul Rafeh Naqash
No Relationships to Disclose
 
Jessica Mukherjee
No Relationships to Disclose
 
Ashley Bruns
No Relationships to Disclose
 
Richard Piekarz
No Relationships to Disclose
 
Jerry M. Collins
No Relationships to Disclose
 
Larry Anderson
No Relationships to Disclose
 
Brandon Miller
No Relationships to Disclose
 
Ralph E. Parchment
Employment - Leidos Biomedical Research
Stock and Other Ownership Interests - Leidos; SciTech Development LLC
Patents, Royalties, Other Intellectual Property - Cambridge University Press for The Biological Basis of Cancer; Named Inventor on US Patent 9,644,037; Named inventor on US Patent US8709379 B2
Travel, Accommodations, Expenses - Sanofi/Aventis
 
Larry V Rubinstein
No Relationships to Disclose
 
Shivaani Kummar
Stock and Other Ownership Interests - Arxeon Therapeutics (I); PathomIQ
Honoraria - Bayer
Consulting or Advisory Role - Bayer; Boehringer Ingelheim; Cadila Pharmaceuticals (I); Gilead Sciences; Harbour BioMed; MedTree (I); Mundipharma; Seagen; ShangPharma Innovation; SpringWorks Therapeutics
Research Funding - ADC Therapeutics (Inst); Advenchen Laboratories (Inst); Amgen (Inst); Astex Pharmaceuticals (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Corvus Pharmaceuticals (Inst); Dynavax Technologies (Inst); Genome & Company (Inst); Incyte (Inst); Jounce Therapeutics (Inst); Loxo (Inst); Moderna Therapeutics (Inst); Pfizer (Inst); Plexxikon (Inst); Seagen (Inst); Taiho Pharmaceutical (Inst)
Travel, Accommodations, Expenses - Bayer
 
Elad Sharon
No Relationships to Disclose
 
Howard Streicher
No Relationships to Disclose
 
Alice P. Chen
No Relationships to Disclose
 
James H. Doroshow
No Relationships to Disclose